The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world analysis of peritoneal metastasis from renal cell carcinoma: Meet-Uro 27 study.
 
Marco Stellato
No Relationships to Disclose
 
Sebastiano Buti
Consulting or Advisory Role - BMS; BMS; Ipsen; Merck/Pfizer; MSD; Pfizer; Pfizer
Speakers' Bureau - BMS; Ipsen; Merck/Pfizer; MSD; Pfizer
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Marco Maruzzo
No Relationships to Disclose
 
Giuseppe Fotia
No Relationships to Disclose
 
Mariella Sorarù
No Relationships to Disclose
 
Maria Bassanelli
No Relationships to Disclose
 
Brigida Anna Maiorano
No Relationships to Disclose
 
Francesco Grillone
No Relationships to Disclose
 
Luca Galli
Expert Testimony - Bristol-Myers Squibb/Celgene; Janssen Oncology; MSD; Pfizer; Pfizer
 
Roberto Filippi
No Relationships to Disclose
 
Martina Fanelli
No Relationships to Disclose
 
Michele Dionese
No Relationships to Disclose
 
Michele Maffezzoli
No Relationships to Disclose
 
Bruno Vincenzi
Consulting or Advisory Role - abbott; GlaxoSmithKline; Lilly
Speakers' Bureau - PharmaMar
Research Funding - BD Bard
 
Giuseppe Procopio
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb (BMS); Eisai; Ipsen; Janssen; Merck Sharp & Dohme; MSD Oncology; Novartis; Pfizer
Research Funding - Astellas Pharma; Ipsen; Janssen Oncology
 
Elena Verzoni
No Relationships to Disclose